1 study found for:    NCT01874756
Show Display Options
Download search resultsDownload the search results for:
NCT01874756 (1 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: LY500307 150mg;   Drug: LY500307 75mg;   Drug: Placebo

Indicates status has not been verified in more than two years